T1	p 349 437	360 ASA physical status I-III patients undergoing total abdominal hysterectomy ( TAH ) .
T2	p 814 844	Twenty-two percent of patients
T3	i 35 95	ondansetron , droperidol , perphenazine , and metoclopramide
T4	i 211 293	intravenous ( i.v . ) ondansetron , droperidol , perphenazine , and metoclopramide
T5	i 488 499	ondansetron
T6	i 507 517	droperidol
T7	i 528 540	perphenazine
T8	i 548 562	metoclopramide
T9	i 571 581	or placebo
T10	i 665 679	metoclopramide
T11	o 117 136	nausea and vomiting
T12	o 617 628	Hypotension
T13	o 873 882	sedated .
T14	o 921 959	severe nausea , retching , or vomiting
T15	o 973 1003	severe emetic sequelae ( SES )
T16	o 1234 1237	SES
T17	o 1304 1317	ineffective .
T18	o 1376 1385	effective
T19	o 1399 1421	antiemetic prophylaxis
T20	o 1452 1474	free of side effects .
T21	o 1520 1558	best choice for antiemetic prophylaxis